Microbiology and Immunology

You are here

Home > Publications > Publications

Publications

Found 1031 results
Author [ Title(Asc)] Type Year
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 
R
Totaro KA, Barthelme D, Simpson PT, Jiang X, Lin G, Nathan C, Sauer RT, Sello JK.  2017.  Rational Design of Selective and Bioactive Inhibitors of the Mycobacterium tuberculosis Proteasome.. ACS Infect Dis. 3(2):176-181.
Kadekoppala M, Cheresh P, Catron D, Ji DD, Deitsch K, Wellems TE, Seifert HS, Haldar K.  2001.  Rapid recombination among transfected plasmids, chimeric episome formation and trans gene expression in Plasmodium falciparum.. Mol Biochem Parasitol. 112(2):211-8.
Kafsack BFC, Pena JDO, Coppens I, Ravindran S, Boothroyd JC, Carruthers VB.  2009.  Rapid membrane disruption by a perforin-like protein facilitates parasite exit from host cells.. Science. 323(5913):530-3.
Zhang X, Alexander N, Leonardi I, Mason C, Kirkman LA, Deitsch KW.  2019.  Rapid antigen diversification through mitotic recombination in the human malaria parasite Plasmodium falciparum.. PLoS Biol. 17(5):e3000271.
Yu EYoung, Yen W-F, Steinberg-Neifach O, Lue NF.  2010.  Rap1 in Candida albicans: an unusual structural organization and a critical function in suppressing telomere recombination.. Mol Cell Biol. 30(5):1254-68.
Q
Kass-Eisler A, Falck-Pedersen E, Alvira M, Rivera J, Buttrick PM, Wittenberg BA, Cipriani L, Leinwand LA.  1993.  Quantitative determination of adenovirus-mediated gene delivery to rat cardiac myocytes in vitro and in vivo.. Proc Natl Acad Sci U S A. 90(24):11498-502.
P
Yarnall M, Rowe TC, Holloman WK.  1984.  Purification and properties of nuclease gamma from Ustilago maydis.. J Biol Chem. 259(5):3026-32.
Rowe TC, Rusche JR, Brougham MJ, Holloman WK.  1981.  Purification and properties of a topoisomerase from Ustilago maydis.. J Biol Chem. 256(20):10354-61.
Kotani H, Kmiec EB, Holloman WK.  1993.  Purification and properties of a cruciform DNA binding protein from Ustilago maydis.. Chromosoma. 102(5):348-54.
Rusche JR, Rowe TC, Holloman WK.  1980.  Purification and characterization of nuclease beta from Ustilago maydis.. J Biol Chem. 255(19):9117-23.
Ma X, Saitoh N, Curtis PJ.  1993.  Purification and characterization of a nuclear DNA-binding factor complex containing topoisomerase II and chromosome scaffold protein 2.. J Biol Chem. 268(9):6182-8.
Martin A, Schneider S, Schwer B.  2002.  Prp43 is an essential RNA-dependent ATPase required for release of lariat-intron from the spliceosome.. J Biol Chem. 277(20):17743-50.
Cao S, Liu J, Song L, Ma X.  2005.  The protooncogene c-Maf is an essential transcription factor for IL-10 gene expression in macrophages.. J Immunol. 174(6):3484-92.
Kim J-H, Wei J-R, Wallach JB, Robbins RS, Rubin EJ, Schnappinger D.  2011.  Protein inactivation in mycobacteria by controlled proteolysis and its application to deplete the beta subunit of RNA polymerase.. Nucleic Acids Res. 39(6):2210-20.
Holloman WK.  1975.  A protein from Ustilago which forms an acid-soluble complex with deoxyribonucleic acid.. J Biol Chem. 250(8):2993-300.
Veazey RS, Ketas TJ, Dufour J, Moroney-Rasmussen T, Green LC, Klasse PJ, Moore JP.  2010.  Protection of rhesus macaques from vaginal infection by vaginally delivered maraviroc, an inhibitor of HIV-1 entry via the CCR5 co-receptor.. J Infect Dis. 202(5):739-44.
Veazey RS, Klasse PJohan, Schader SM, Hu Q, Ketas TJ, Lu M, Marx PA, Dufour J, Colonno RJ, Shattock RJ et al..  2005.  Protection of macaques from vaginal SHIV challenge by vaginally delivered inhibitors of virus-cell fusion.. Nature. 438(7064):99-102.
Veazey RS, Springer MS, Marx PA, Dufour J, Klasse PJohan, Moore JP.  2005.  Protection of macaques from vaginal SHIV challenge by an orally delivered CCR5 inhibitor.. Nat Med. 11(12):1293-4.
Nathan C, Calingasan N, Nezezon J, Ding A, M Lucia S, La Perle K, Fuortes M, Lin M, Ehrt S, Kwon NSoo et al..  2005.  Protection from Alzheimer's-like disease in the mouse by genetic ablation of inducible nitric oxide synthase.. J Exp Med. 202(9):1163-9.
K Darwin H, Ehrt S, Gutierrez-Ramos J-C, Weich N, Nathan CF.  2003.  The proteasome of Mycobacterium tuberculosis is required for resistance to nitric oxide.. Science. 302(5652):1963-6.
Giardina SF, Valdambrini E, J Warren D, Barany F.  2021.  PROTACs: Promising Approaches for Epigenetic Strategies to Overcome Drug Resistance.. Curr Cancer Drug Targets. 21(4):306-325.
Yu EYoung, Wang F, Lei M, Lue NF.  2008.  A proposed OB-fold with a protein-interaction surface in Candida albicans telomerase protein Est3.. Nat Struct Mol Biol. 15(9):985-9.
Ross CF, Brougham MJ, Holloman WK, Ross WE.  1983.  Properties of a purified nuclear topoisomerase from L1210 cells.. Biochim Biophys Acta. 741(2):230-6.
Ma X, Montaner LJ.  2000.  Proinflammatory response and IL-12 expression in HIV-1 infection.. J Leukoc Biol. 68(3):383-90.
Sanders RW, Moore JP.  2024.  Progress on priming HIV-1 immunity.. Science. 384(6697):738-739.